- Home
- ASPS vs SYBX Comparison
ASPS vs SYBX Comparison
Compare ASPS & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASPS
- SYBX
- Stock Information
- Founded
- ASPS 1999
- SYBX N/A
- Country
- ASPS Luxembourg
- SYBX United States
- Employees
- ASPS N/A
- SYBX N/A
- Industry
- ASPS Other Consumer Services
- SYBX Biotechnology: Pharmaceutical Preparations
- Sector
- ASPS Consumer Discretionary
- SYBX Health Care
- Exchange
- ASPS Nasdaq
- SYBX Nasdaq
- Market Cap
- ASPS 19.8M
- SYBX 17.0M
- IPO Year
- ASPS N/A
- SYBX N/A
- Fundamental
- Price
- ASPS $0.62
- SYBX $1.37
- Analyst Decision
- ASPS
- SYBX Hold
- Analyst Count
- ASPS 0
- SYBX 3
- Target Price
- ASPS N/A
- SYBX $1.00
- AVG Volume (30 Days)
- ASPS 188.9K
- SYBX 71.5K
- Earning Date
- ASPS 10-24-2024
- SYBX 11-12-2024
- Dividend Yield
- ASPS N/A
- SYBX N/A
- EPS Growth
- ASPS N/A
- SYBX N/A
- EPS
- ASPS N/A
- SYBX N/A
- Revenue
- ASPS $153,278,000.00
- SYBX $2,777,000.00
- Revenue This Year
- ASPS $15.33
- SYBX N/A
- Revenue Next Year
- ASPS $32.37
- SYBX N/A
- P/E Ratio
- ASPS N/A
- SYBX N/A
- Revenue Growth
- ASPS 5.19
- SYBX 292.23
- 52 Week Low
- ASPS $0.62
- SYBX $1.22
- 52 Week High
- ASPS $3.71
- SYBX $5.12
- Technical
- Relative Strength Index (RSI)
- ASPS 30.70
- SYBX 41.68
- Support Level
- ASPS $0.71
- SYBX $1.44
- Resistance Level
- ASPS $0.86
- SYBX $1.88
- Average True Range (ATR)
- ASPS 0.08
- SYBX 0.09
- MACD
- ASPS -0.00
- SYBX -0.00
- Stochastic Oscillator
- ASPS 1.14
- SYBX 1.92
About ASPS Altisource Portfolio Solutions S.A.
Altisource Portfolio Solutions SA is an integrated service provider and marketplace for the real estate and mortgage industries. It operates via two reportable segments namely Servicer and Real Estate and Origination. The Servicer and Real Estate segment provides loan servicers and real estate investors with solutions and technologies that span the mortgage and real estate lifecycle. The Origination segment provides originators with solutions and technologies that span the mortgage origination lifecycle. Altisource primarily serves financial institutions, government-sponsored enterprises, and originators in the United States, with the majority of revenue flowing from field services and mortgage and real estate solutions.
About SYBX Synlogic Inc.
Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.